tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mitchell Kapoor, 441 are a BUY (89.45%), 39 are a HOLD (7.91%), 13 are a SELL (2.64%).
Analyst Mitchell Kapoor, carries an average stock price target met ratio of 30.99% that have a potential upside of 42.79% achieved within 70 days. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.
Mitchell Kapoor’s has documented 936 price targets and ratings displayed on 38 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on INCY, yte.
Analyst best performing recommendations are on CBIO (CATALYST BIOSCIENCES).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $30 was fulfilled within 4 days with a profit of $10.86 (56.74%) receiving and performance score of 141.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2021
$36
$-0.01 (-0.03%)
$36
3 years 10 months 4 days ago
(28-Nov-2022)
3/3 (100%)
$0.35 (0.98%)
267
Buy Since 15-Feb-2022
$36
$-0.01 (-0.03%)
$35
3 years 10 months 10 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
145
Buy Since 10-Aug-2021
$36
$-0.01 (-0.03%)
$35
3 years 10 months 10 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
204
Hold Since 22-Nov-2022
$36
$-0.01 (-0.03%)
3 years 10 months 10 days ago
(22-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Buy Since 28-Oct-2022
$36
$-0.01 (-0.03%)
$25
3 years 10 months 11 days ago
(21-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
Which stock is Mitchell Kapoor most bullish on?
Which stock is Mitchell Kapoor most reserved on?
